Skip to main content
Premium Trial:

Request an Annual Quote

Alan Edrick, Charles Best, Patrick Balthrop, Thomas Erickson, and Mark Chandler

Premium

BioSource International has appointed Alan Edrick executive vice president and chief financial officer.

Edrick replaces Charles Best, who resigned from the company earlier this month.

Edrick has more than 15 years of financial management and public accounting experience, BioSource said. Most recently, he served as senior vice president and chief financial officer at North American Scientific, a medical device and specialty pharmaceutical company. Prior to this, he worked for several years at PriceWaterhouse in various positions.

He holds a BA degree from UCLA and an MBA from UCLA's Anderson School of Business.


Luminex has named Patrick Balthrop as CEO and president, filling the two top spots that were being overseen by Thomas Erickson, a professional interim president.

Balthrop comes to Luminex from Fisher Scientific International, where he was president of the Fisher Healthcare division since 2002. Previously, he was head of worldwide commercial diagnostics operations at Abbott Diagnostics.

Balthrop was appointed 20 months after Luminex's CEO Mark Chandler left the company to head a spin-off based on the company's Rules-Based Medicine project. Luminex expects Balthorp to become a company director.

Erickson will remain as a company director and chairman of the executive committee, subject to his election to the board during the company's annual meeting of stockholders May 20.

To sweeten the deal for Balthorp, Luminex gave him a restricted stock grant for 200,000 shares of common stock at $9.36 per share, and a contractual option grant to buy 500,000 shares of common stock.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.